VARIZIG (Aptevo BioTherapeutics LLC)
Welcome to the PulseAid listing for the VARIZIG drug offered from Aptevo BioTherapeutics LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aptevo BioTherapeutics LLC |
NON-PROPRIETARY NAME: | Varicella Zoster Immune Globulin (Human) |
SUBSTANCE NAME: | HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2016-07-01 |
END MARKETING DATE: | 0000-00-00 |
VARIZIG HUMAN PRESCRIPTION DRUG Details:
Item Description | VARIZIG from Aptevo BioTherapeutics LLC |
LABELER NAME: | Aptevo BioTherapeutics LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125([iU]/1) |
START MARKETING DATE: | 2016-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70504-0126_097e23f2-3e24-41cd-b2f8-410b2db147b4 |
PRODUCT NDC: | 70504-0126 |
APPLICATION NUMBER: | BLA125430 |
Other HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers: